Cathie Wood's ARK Investment Purchases 560K Shares of Intellia Therapeutics

martes, 19 de agosto de 2025, 5:26 am ET1 min de lectura
NTLA--

ARK Investment has purchased 560,600 shares of Intellia Therapeutics. The stock has a Seeking Alpha quant rating of Hold, with the factor grades given to momentum. Cathie Wood's ARK Investment has increased its holdings in the biotech and gene editing company.

Cathie Wood's ARK Investment Purchases 560K Shares of Intellia Therapeutics

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios